Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2009
10/15/2009WO2009126123A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009125923A2 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125808A1 Aminocyclohexyl derivative
10/15/2009WO2009125597A1 Acylthiourea compound or salt thereof, and use of the compound or the salt
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009124956A1 Pyridine derivatives used to treat orexin related disorders
10/15/2009WO2009124906A2 Method for preparing argatroban monohydrate
10/15/2009WO2009124903A1 Substituted pyridazinylmethyl sulfonamides
10/15/2009WO2009124883A1 Novel 1,3-dihydro-benzoimidazol-2-ones as m1 agonists
10/15/2009WO2009124882A1 Novel piperidinyl-1,3-dihydro-benzoimidazol-2-ones as m1 agonists
10/15/2009WO2009124734A2 Substituted sulfonamide derivatives
10/15/2009WO2009124733A1 Substituted sulfonamide derivatives
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009099933A3 Preparation of esomeprazole magnesium and hydrates thereof
10/15/2009WO2009095712A3 4-(3-amin0pyraz0le) pyrimidine derivatives for use as jak kinase inhibitors in the treatment of cancer
10/15/2009WO2009068194A3 Halogen-substituted δ1 pyrrolines
10/15/2009WO2009016460A8 Pyrazole compounds and their use as raf inhibitors
10/15/2009US20090259047 contacting (S)-omeprazole freebase or its sodium/potassium salt with inorganic or organic acid salt of the barium (barium chloride, barium sulfate, barium oxalate, barium acetate) in a suitable solvent ( methanol)in presence of a base ( NaOH) to form (S)-omeprazole barium; helicobacter infections
10/15/2009US20090259046 Cyclic Amine Compounds and Agents for Pest Control
10/15/2009US20090259042 Electrochromic compounds
10/15/2009US20090259041 Quinoline carboxylic acid-o,o bis-acyloxy borate and process of making
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
10/15/2009US20090258910 benzo[1,3]dioxol-5-yl-carbamic acid 6-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester and benzo[1,3]dioxol-5-yl-carbamic acid 8-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester;
10/15/2009US20090258908 Crystalline S-Omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258900 Amide derivative
10/15/2009US20090258899 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
10/15/2009US20090258885 Diphenylmethane Derivatives as Inhibitors of Leukotriene Biosynthesis
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258883 1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds
10/15/2009US20090258882 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors
10/15/2009US20090258881 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament
10/15/2009US20090258876 Novel indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009US20090258866 CGRP Receptor Antagonists
10/15/2009US20090258862 Niacin receptor agonists, compositions containing such compounds and methods of treatment
10/15/2009US20090258856 Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
10/15/2009US20090258853 Somatostatin Agonists
10/15/2009US20090258852 Inhibitors of Checkpoint Kinases
10/15/2009US20090258851 Diaryl substituted alkanes
10/15/2009US20090258016 Substituted imidazole derivatives
10/15/2009US20090256473 Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same
10/15/2009US20090256468 Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/15/2009CA2725425A1 Homocysteine synthase inhibitor
10/15/2009CA2720950A1 Compounds and compositions as modulators of gpr119 activity
10/15/2009CA2720793A1 Substituted sulfonamide derivatives
10/15/2009CA2720735A1 Substituted sulfonamide derivatives
10/15/2009CA2720552A1 Acylthiourea compound or salt thereof, and use thereof
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2719778A1 Method for preparing argatroban monohydrate
10/15/2009CA2719650A1 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009CA2718770A1 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
10/14/2009EP2108649A1 Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists
10/14/2009EP2108648A1 Selected CGRP antagonists, method for their manufacture and use as medicines
10/14/2009EP2108642A1 Jak inhibitor
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP2108016A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
10/14/2009EP2108015A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/14/2009EP2108012A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/14/2009EP1893603B1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
10/14/2009EP1685138B1 Regiospecific synthesis of nicotine derivatives
10/14/2009EP1594858B1 Novel benzoimidazole derivatives useful as antiproliferative agents
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP0970050B2 Process for the preparation of 5,6-dihydro-11h-dibenzo a,d cyclohept-11-enes
10/14/2009CN101558060A Piperidine derivative used for treating chemokine receptor 5 mediated diseases
10/14/2009CN101558059A Hepatitis C virus inhibitors
10/14/2009CN101558058A Modulators of CB1 receptors
10/14/2009CN101558057A 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
10/14/2009CN101558056A Process for production of anthranilamide compound
10/14/2009CN101558055A Spiro substituted compounds as angiogenesis inhibitors
10/14/2009CN101558049A Substituted pyrazole and triazole compounds as KSP inhibitors
10/14/2009CN101558040A Dihydropyridine derivatives useful as protein kinase inhibitors
10/14/2009CN101555257A Synthesizing method of 1-aryl-3, 5-dimethyl pyrazole-4-formic acid organotin derivatives and applications
10/14/2009CN101555246A Halogen-containing asymmetry phthalocyanines compound, preparation method and application thereof
10/14/2009CN100549012C Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors
10/14/2009CN100549006C Mitotic kinesin inhibitors
10/14/2009CN100549005C Optically active dihydropyridine derivative
10/14/2009CN100549004C Spirocyclic heterocyclic derivatives and methods of their use
10/14/2009CN100548992C Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
10/14/2009CN100548985C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B
10/14/2009CN100548980C Isoindoline derivative
10/14/2009CN100548299C Excitatory amino acid receptor antagonists
10/13/2009US7601837 Quinoline derivatives and their use as 5-HT6 ligands
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601753 Pyrrolidine melanocortin-specific compounds
10/13/2009US7601743 controlling insects or representatives of the order Acarina
10/13/2009US7601742 Pyrrolidones with anti-HIV activity
10/13/2009US7601738 Excitatory amino acid receptor antagonists
10/13/2009US7601714 Pyrimidine derivatives useful as inhibitors of PKC-theta
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009US7601435 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same
10/13/2009CA2560510C N-(1-arylpyrazol-4yl) sulfonamides and their use as parasiticides
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2419416C Tetrazolyl-phenyl acetamide glucokinase activators
1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 1080